Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 898
Affinity DataIC50: 36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 117nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 407nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 710nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 2.12E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
